Advances in™ Schizophrenia: The Role of Emerging Therapies in Improving Safety and Medication Adherence

CME: 1.0

July 29, 2020
KEYWORDS Primary Care
/ Print / Reprints /
| Share More
/ Text Size+

Recognize unmet needs in schizophrenia treatment and factors that contribute to relapse, including the association between metabolic or other medication adverse effects and treatment nonadherence

Post a comment to this article